JB Pharma: Betting big on India
Our biggest bet is India and the CDMO space, says Nikhil Chopra, CEO, JB Pharma, taking stock of the company's ongoing transition…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
KKR
JB Chemicals closely watching for acquisition opportunities
Nikhil Chopra, CEO and Whole Time Director, JB Chemicals and Pharmaceuticals, tells Akanki Sharma about his focus on acquiring…
My role is to act like a catalyst
Nikhil Chopra recently took over as CEO and Whole-time Director of JB Chemicals & Pharmaceuticals. In a free-wheeling…
KKR to acquire controlling stake in JB Chemicals and Pharmaceuticals
KKR will make the investment through its subsidiaries, Tau Investments Holdings, Tau Holdco, and KKR Asia III Fund Investments
Univercells secures up to €50M investment from KKR platform to speed delivery of manufacturing…
With the new financing, Univercells will focus on scaling the NevoLine platform and the scale-X portfolio with a comprehensive…